Alle Storys
Folgen
Keine Story von november AG mehr verpassen.

november AG

EANS-News: november AG
Publication of consolidated financial results for 2009 / Continued upswing of november AG

Köln (euro adhoc) -

• improved operating profits despite reduced consolidated revenues
 •
consolidated results virtually break-even with EUR –0.3 mio
 • 
reduction of liabilities from EUR 9.9 mio to EUR 6.9 mio
 • increase 
of equity capital from EUR –7.9 mio (2007), EUR –5.6 mio (2008) to 
EUR –3.8 mio (2009)
 • improved liquidity of EUR 0.7 mio
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
annual report/Annual Reports/annual result/Financial Figures/Balance 
Sheet
Subtitle: • improved operating profits despite reduced consolidated 
revenues • consolidated results virtually break-even with EUR –0.3 
mio • reduction of liabilities from EUR 9.9 mio to EUR 6.9 mio • 
increase of equity capital from EUR –7.9 mio (2007), EUR –5.6 mio 
(2008) to EUR –3.8 mio (2009) • improved liquidity of EUR 0.7 mio
The november group, essentially consisting of the
november AG (holding) and the operating units PROGEN Biotechnik GmbH 
and Multimetrix GmbH, achieved consolidated sales renues of EUR 5.3 
mio (previous year EUR 8.1 mio) despite the discontinuation of the 
Axis-Shield product line. Although sales revenues decreased due to 
the transfer of this product range, the consolidated operating 
results increased considerably from EUR -0.7 mio in 2008 to EUR -0.2 
mio in fiscal year 2009. Thus, the restructuring of the november 
group also shows positive results in other important operative 
levels.
Same as previous year (EUR -0.2 mio), consolidated results nearly 
reached break-even in fiscal year 2009 with EUR -0.3 mio. This 
reflects the overall successful restructuring process of the november
group as well as the focus of the operating units on high-margin 
products and profitable services. The consolidated financial results 
improved considerably as compared to the previous year. Due to 
continued restructuring of financial liabilities in 2009 and  as a 
result of interest waivers, the financial results improved to EUR 
-0.1 mio in 2009 as compared to EUR -0.4 mio in 2008.
Liabilities were further decreased in 2009 as compared to the 
previous year (2009:  EUR 6.9 mio, 2008: EUR 9.9 mio). Accordingly, 
the total equity increased considerably to EUR -3.8 mio as compared 
to previous years (2008: EUR -5.7 mio, 2007: EUR -7.9 mio). 
Additional measures were implemented already in the fist quarter of 
2010 to further reduce liabilities of the group. For results and 
comments, please refer to the 1st quarter report 2010. For fiscal 
year ending December 31, 2009 the november group shows a liquidity of
approx. EUR 0.7 mio despite significant loan repayments.
Please refer to the consolidated management report 2009 including all
certified financial results under 
www.november.eu/company-profile/reports.html.
Presentation of corporate business results for fiscal year 2009 at 
the next annual general meeting of the november AG which is planned 
for July 21, 2010 in Cologne.
end of announcement                               euro adhoc

Further inquiry note:

Christoph Schmitz
Leiter Finanzen, Controlling
Tel.: +49 (0) 221- 820 05 20 -10
E-Mail: info@november.de

Branche: Biotechnology
ISIN: DE000A0Z24E9
WKN: A0Z24E
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade

Weitere Storys: november AG
Weitere Storys: november AG